Success Metrics

Clinical Success Rate

83.3%

Based on 5 completed trials

Completion Rate

83%(5/6)

Active Trials

1(8%)

Results Posted

40%(2 trials)

Terminated

1(8%)

Phase Distribution

Ph early_phase_1

Ph phase_2

23%

Ph not_applicable

Ph phase_3

23%

Ph phase_1

Ph phase_4

31%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution13 total trials

Early Phase 1First-in-human

1(7.7%)

Phase 1Safety & dosage

1(7.7%)

Phase 2Efficacy & side effects

3(23.1%)

Phase 3Large-scale testing

3(23.1%)

Phase 4Post-market surveillance

4(30.8%)

N/ANon-phased studies

1(7.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(5)

Terminated(1)

Other(6)

Detailed Status

unknown6

Completed5

Terminated1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

83.3%

Most Advanced

Phase 4

Trials by Phase

Early Phase 11 (7.7%)

Phase 11 (7.7%)

Phase 23 (23.1%)

Phase 33 (23.1%)

Phase 44 (30.8%)

N/A1 (7.7%)

Trials by Status

completed538%

terminated18%

recruiting18%

unknown646%

Recent Activity

1 active trials

Showing 5 of 13

recruitingphase_2

"Sexual Health Assessment of TinidaZole Against M. Genitalium (SHAZAM)"

NCT07088419

unknownphase_4

Helicobacter Pylori Rescue Treatment Containing Tetracycline in Patients Allergic to Penicillin

NCT04264663

unknownphase_4

Clinical Trials (13)

Showing 13 of 13 trials

NCT07088419Phase 2

"Sexual Health Assessment of TinidaZole Against M. Genitalium (SHAZAM)"

Recruiting

NCT04264663Phase 4

Helicobacter Pylori Rescue Treatment Containing Tetracycline in Patients Allergic to Penicillin

Unknown

NCT04122287Phase 4

Helicobacter Pylori First-line Treatment in Patients Allergic to Penicillin

Unknown

NCT04652284Phase 3

Effectiveness of Rifabutin for Treatment of Helicobacter Pylori

Unknown

NCT02942485Phase 4

Treatment of Giardia Lamblia Infections in Children

Terminated

NCT00322465Phase 2

NGU: Doxycycline (Plus or Minus Tinidazole) Versus Azithromycin (Plus or Minus Tinidazole)

Completed

NCT01591889Phase 1

Crossover Bioequivalence Study of Tinidazole 500 mg Tablets Under Fed Conditions

Completed

NCT03139253Phase 4

Antimicrobial Susceptibility Testing Guided Triple Therapy in Salvage Helicobacter Pylori Treatment

Unknown

NCT00229216Phase 3

Treatment of Bacterial Vaginosis With Oral Tinidazole

Completed

NCT00003617Phase 3

Chlorambucil Compared With No Further Therapy Following Anti-Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach

Unknown

NCT00811096Phase 2

Pilot Human Study of Tinidazole Efficacy For Radical Cure Of Plasmodium Vivax

Completed

NCT00510614Early Phase 1

Tinidazole for Recurrent Bacterial Vaginosis: A Pilot Study

Completed

NCT00787553Not Applicable

Tinidazole Versus Cefazolin Antibiotic Prophylaxis of Vaginal and Abdominal Hysterectomy

Unknown

All 13 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 13